Industry News
First US implant for Ventracor
Sydney-based Ventracor (ASX:VCR) has implanted its first VentrAssist left ventricular assist system (LVAS) in the United States. [ + ]
In Brief: Polartechnics, Medsaic, Epitan, Genesis Research and Development Corporation, PharmAust, Advanced Molecular Technologies
Polartechnics has announced an increase in unaudited revenue results for the financial year ending June 2005 by 280 per cent to AUD$6 million, compared to $2.1 million for the previous financial year. [ + ]
GM canola found in Australian consignment to Japan
Routine tests by the Australian Barley Board have detected traces of genetically modified canola seed in a small consignment canola to Japan, triggering a strong reaction from anti-GM activist organisations. [ + ]
Columna to receive AUD$3.5 million in QBF funding
Spinal implant technology company Columna has secured AUD$3.5 million in funding from Queensland BioCapital Funds for the development of spinal orthopaedic implants. [ + ]
LabTech set to commercialise microbial streaking technology
South Australian technology company LabTech Systems (NSX: LTS) is poised to undertake commercialisation of its newly invented brush applicator for the automation of routine microbiology testing in pathology and science laboratories. [ + ]
Market will see a very different Amrad: chairman
Since CEO Pete Smith and chairman Bob Moses resigned in May, Amrad (ASX:AML) has kept quiet about its strategic direction. Ruth Beran spoke to chairman Ian Davis about the refocusing of the company. [ + ]
Proteome Systems reports positive results for Alzheimer's compound
Sydney proteomics R&D company Proteome Systems (ASX:PXL) has reported positive results from pre-clinical trials of its lead compound, the potent antioxidant EUK-189, in an animal model of Alzheimer's disease. [ + ]
Drought tolerance gene identified in wheat
In the nick of time, climatically speaking, an Australian National University research team has cloned a plant gene that could markedly increase water-use efficiency in major food crops, including cereals. [ + ]
Biocomm and Monash University collaborate to establish CNSBio
Business development and seed finance company Biocomm Services and Monash University, through Monash Commercial, have established CNSBio -- a new Melbourne-based company focused on the research and treatment of pain associated with cancer and chronic inflammatory diseases. [ + ]
Stem Cell Sciences raises £6 million on AIM
Despite terrorist attacks in London last week, BioTech Capital (ASX:BTC) investee company Stem Cell Sciences has raised £6 million (approximately AUD$14 million) as part of its initial public offering and listing on London's Alternative Investment Market (AIM). [ + ]
Former Amrad CEO takes top job at Cerylid
Two months after his surprise resignation as CEO of Amrad (ASX:AML), Peter Smith has taken on a part-time role as CEO of Cerylid Biosciences, an unlisted company of which Amrad is the major shareholder. [ + ]
In Brief: Medical Developments International, Ventracor, Anadis, Ozgen, GlaxoSmithKline
Chris Weaver has resigned as Medical Developments Internationa (ASX:MVP) managing director and CEO to take up an executive management position with a bank. Current CFO Jeremy Payling will act as interim CEO while the company searches for a new CEO. [ + ]
Rockeby granted US patent for candida detection kit
Rockeby biomed (ASX:RBY) has been awarded an additional US patent over its SysCan3 Hospital Test Kit for use in the diagnosis of candida infections such as systemic candidiasis and thrush. [ + ]
GroPep clarifies its recurrent miscarriage project to the market
Media speculation has forced Adelaide-based GroPep (ASX:GRO) to clarify its position on ethics committee approval for a clinical study of an infertility drug. [ + ]
Relenza inventor Mark von Itzstein wins Adrien Albert Award
Prof Mark von Itzstein has won the RACI's Adrien Albert Award for his contribution to medicinal chemistry through the design and development of anti-influenza virus drug Relenza. [ + ]
